bumetanide has been researched along with Papilledema in 3 studies
Papilledema: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bumetanide (BU) has potential efficacy against cytotoxic oedema." | 5.91 | Bumetanide Rescues Aquaporin-4 Depolarization via Suppressing β-Dystroglycan Cleavage and Provides Neuroprotection in Rat Retinal Ischemia-Reperfusion Injury. ( Chen, C; Fan, P; Gan, S; Hu, J; Huang, J; Lu, W; Qiu, G; Ran, J; Xu, J; Xu, S; Xue, K; Zhang, L, 2023) |
| "Bumetanide (BU) has potential efficacy against cytotoxic oedema." | 1.91 | Bumetanide Rescues Aquaporin-4 Depolarization via Suppressing β-Dystroglycan Cleavage and Provides Neuroprotection in Rat Retinal Ischemia-Reperfusion Injury. ( Chen, C; Fan, P; Gan, S; Hu, J; Huang, J; Lu, W; Qiu, G; Ran, J; Xu, J; Xu, S; Xue, K; Zhang, L, 2023) |
| "Medical treatment of idiopathic intracranial hypertension is often ineffective." | 1.37 | Resolution of headache and papilledema in idiopathic intracranial hypertension associated with inhibition of Na+-K+-2Cl- cotransport. ( Kahle, KT; Staley, KJ; Walcott, BP, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C | 2 |
| Fan, P | 2 |
| Zhang, L | 2 |
| Xue, K | 2 |
| Hu, J | 2 |
| Huang, J | 2 |
| Lu, W | 2 |
| Xu, J | 2 |
| Xu, S | 2 |
| Qiu, G | 2 |
| Ran, J | 2 |
| Gan, S | 2 |
| Kahle, KT | 1 |
| Walcott, BP | 1 |
| Staley, KJ | 1 |
| Ochoa-de la Paz, LD | 1 |
| Lezama, R | 1 |
| Toscano, B | 1 |
| Pasantes-Morales, H | 1 |
3 other studies available for bumetanide and Papilledema
| Article | Year |
|---|---|
Bumetanide Rescues Aquaporin-4 Depolarization via Suppressing β-Dystroglycan Cleavage and Provides Neuroprotection in Rat Retinal Ischemia-Reperfusion Injury.
Topics: Animals; Aquaporin 4; Bumetanide; Dystroglycans; Edema; Matrix Metalloproteinase 9; Neuroprotection; | 2023 |
Bumetanide Rescues Aquaporin-4 Depolarization via Suppressing β-Dystroglycan Cleavage and Provides Neuroprotection in Rat Retinal Ischemia-Reperfusion Injury.
Topics: Animals; Aquaporin 4; Bumetanide; Dystroglycans; Edema; Matrix Metalloproteinase 9; Neuroprotection; | 2023 |
Bumetanide Rescues Aquaporin-4 Depolarization via Suppressing β-Dystroglycan Cleavage and Provides Neuroprotection in Rat Retinal Ischemia-Reperfusion Injury.
Topics: Animals; Aquaporin 4; Bumetanide; Dystroglycans; Edema; Matrix Metalloproteinase 9; Neuroprotection; | 2023 |
Bumetanide Rescues Aquaporin-4 Depolarization via Suppressing β-Dystroglycan Cleavage and Provides Neuroprotection in Rat Retinal Ischemia-Reperfusion Injury.
Topics: Animals; Aquaporin 4; Bumetanide; Dystroglycans; Edema; Matrix Metalloproteinase 9; Neuroprotection; | 2023 |
Resolution of headache and papilledema in idiopathic intracranial hypertension associated with inhibition of Na+-K+-2Cl- cotransport.
Topics: Adolescent; Bumetanide; Disease Progression; Female; Headache; Humans; Papilledema; Pseudotumor Cere | 2011 |
Mechanisms of chloride influx during KCl-induced swelling in the chicken retina.
Topics: Acetates; Animals; Bumetanide; Chickens; Chloride Channels; Chlorides; Diuretics; Excitatory Amino A | 2005 |